The Lupus Foundation of America (LFA) is excited to share that enrollment for the MiSLE (Mesenchymal Stromal Cells in Systemic Lupus Erythematosus) study was officially completed on February 21, 2025 ...

we committed nearly $4 million over five years to co-fund a major study of mesenchymal (adult) stromal cells as a new treatment for moderate to severe lupus. This study is the first step in ...

Human extracellular matrices can be edited in their composition using the CRISPR/Cas9 system, leading to materials exhibiting tailored regenerative capacities.

"This first mesenchymal stromal cell therapy approval demonstrates ... A single donor can provide enough cells to treat 400 patients. Support for the approval came from a phase III, single-arm ...